Does peroxisome proliferator-activated receptor γ genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?

被引:66
|
作者
Franks, PW
Luan, J
Browne, PO
Harding, AH
O'Rahilly, S
Chatterjee, VKK
Wareham, NJ
机构
[1] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England
[2] Univ Cambridge, Inst Publ Hlth, Dept Med & Clin Biochem, Cambridge CB2 2SR, England
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2004年 / 53卷 / 01期
基金
英国惠康基金; 英国医学研究理事会;
关键词
D O I
10.1016/j.metabol.2003.08.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxisome proliferator-activated receptor gamma (PPARgamma) has a role in controlling adipogenesis and insulin sensitivity. Previous studies have suggested that a common polymorphism (Pro12Ala) in the PPARgamma-2 isoform of this gene may be associated with markers of insulin resistance. We have previously shown that in combination, the relationships with fasting insulin of dietary polyunsaturated to saturated fatty acid ratio (P:S ratio) and physical activity are additive. We have also demonstrated that the association between P:S ratio and fasting insulin level is modified by the Pro12Ala genotype. The purpose of the present study was to investigate whether the Pro12Ala genotype modified the combined relationships of P:S ratio and physical activity level (PAL) on fasting insulin concentration. A population-based cohort of 506 Caucasian men and women aged 31 to 71 years was genotyped for the Pro12Ala polymorphism. P:S ratio was assessed by food-frequency questionnaire (FFQ) and PAL was estimated from 4 days of free-living heart rate monitoring following individual calibration of heart rate against energy expenditure during an exercise stress test. The combined associations of PAL and P:S ratio on fasting insulin level were examined stratified by Pro12Ala genotypes in a dominant model for the Ala allele. Among Pro allele homozygotes, there was no interaction between PAL and P:S ratio on fasting insulin (P = .929). However, in carriers of the Ala allele the association of P:S ratio with fasting insulin was modified by activity level (interaction P = 0.038). In those who were inactive and carried the Ala allele, the age-, sex-, and body mass-adjusted relationship between P:S ratio and log insulin was not significant (beta = -0.03, P =.93). In contrast, in physically active Ala carriers, the association of P:S ratio with log fasting insulin was highly significant (beta = -0.93, P = .004). In conclusion, this study examined the modification by PPARgamma genotype of the association between energy expenditure, P:S ratio, and fasting insulin level, a measure of insulin resistance. These data show that in Pro allele homozygotes the combined associations of P:S ratio and PAL are additive. In contrast, in Ala allele carriers, PAL modifies the association between P:S ratio and fasting insulin level in a multiplicative manner. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 50 条
  • [21] Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with polycystic ovary syndrome: a meta-analysis
    Song-tao Tang
    Chang-jiang Wang
    Hai-qin Tang
    Wen-jia Peng
    You-min Wang
    Qiu Zhang
    Molecular Biology Reports, 2012, 39 : 9649 - 9660
  • [22] Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
    Beamer, BA
    Yen, CJ
    Andersen, BE
    Muller, D
    Elahi, D
    Cheskin, LJ
    Andres, R
    Roth, J
    Shuldiner, AR
    DIABETES, 1998, 47 (11) : 1806 - 1808
  • [23] Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with polycystic ovary syndrome: a meta-analysis
    Tang, Song-tao
    Wang, Chang-jiang
    Tang, Hai-qin
    Peng, Wen-jia
    Wang, You-min
    Zhang, Qiu
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (10) : 9649 - 9660
  • [24] Association of Pro12Ala variant in peroxisome proliferator - Activated receptor with type 2 diabetes mellitus
    Mao, F
    Bin, W
    Hua, C
    DIABETOLOGIA, 2001, 44 : A90 - A90
  • [25] Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy
    Tariq, Khadija
    Malik, Saira Bano
    Ali, Syeda Hafiza Benish
    Maqsood, Sundas Ejaz
    Azam, Aisha
    Muslim, Irfan
    Khan, Muhammad Shakil
    Azam, Maleeha
    Waheed, Nadia Khalida
    Qamar, Raheel
    MOLECULAR VISION, 2013, 19 : 710 - 717
  • [26] Correlation of Peroxisome Proliferator-Activated Receptor (PPAR-γ) mRNA Expression with Pro12Ala Polymorphism in Obesity
    Berhouma, Rym
    Kouidhi, Soumaya
    Ammar, Myriam
    Abid, Hafawa
    Ennafaa, Hajer
    Benammar-Elgaaied, Amel
    BIOCHEMICAL GENETICS, 2013, 51 (3-4) : 256 - 263
  • [27] Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk
    Wang, Wei
    Shao, Yan
    Tang, Shenhua
    Cheng, Xianyong
    Lian, Haifeng
    Qin, Chengyong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 4066 - 4072
  • [28] The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
    Andersen, G
    Ek, J
    Urhammer, SA
    Eiberg, H
    Borch-Johnsen, K
    Hansen, T
    Pedersen, O
    DIABETOLOGIA, 2000, 43 : A87 - A87
  • [29] Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
    Mancini, FP
    Vaccaro, O
    Sabatino, L
    Tufano, A
    Rivellese, AA
    Riccardi, G
    Colantuoni, V
    DIABETES, 1999, 48 (07) : 1466 - 1468
  • [30] Genotyping of peroxisome proliferator-activated receptor gamma (PPAR-γ) polymorphism (Pro12Ala) in Iranian population
    Namvaran, Fatemeh
    Rahimi-Moghaddam, Parvaneh
    Azarpira, Negar
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2011, 16 (03): : 291 - 296